14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MDGL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Madrigal Pharmaceuticals, Inc. stock price up 0.696% on Tuesday
(Updated on Apr 16, 2024)

Sell candidate since Apr 02, 2024 Loss -4.71% PDF

The Madrigal Pharmaceuticals, Inc. stock price gained 0.696% on the last trading day (Tuesday, 16th Apr 2024), rising from $231.37 to $232.98. During the last trading day the stock fluctuated 5.84% from a day low at $222.90 to a day high of $235.92. The price has risen in 6 of the last 10 days but is still down by -4.71% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 thousand more shares were traded than the day before. In total, 338 thousand shares were bought and sold for approximately $78.67 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.62% during the next 3 months and, with a 90% probability hold a price between $232.48 and $342.41 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

MDGL Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 0.696%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Madrigal Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $241.27 and $251.48. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Madrigal Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $216.33 and $201.44. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Madrigal Pharmaceuticals, Inc. finds support just below today's level at $216.33. If this is broken, then the next support from accumulated volume will be at $201.44 and $188.54.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $13.02 between high and low, or 5.84%. For the last week, the stock has had daily average volatility of 3.96%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MDGL) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Madrigal Pharmaceuticals, Inc. to open at $230.60, and during the day (based on 14 day Average True Range), to move between $220.26 and $245.70, which gives a possible trading interval of +/-$12.72 (+/-5.46%) up or down from last closing price. If Madrigal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 10.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $216.33 (7.15%) than the resistance at $265.68 (14.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Madrigal Pharmaceuticals, Inc. stock A Buy?

The Madrigal Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Madrigal Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.285 Sell Candidate Unchanged

Predicted Opening Price for Madrigal Pharmaceuticals, Inc. of Wednesday, April 17, 2024

Fair opening price April 17, 2024 Current price
$230.60 ( 1.02%) $232.98

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MDGL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 243.62 4.57 %
R2 238.65 2.43 %
R1 235.57 1.11 %
Current price: 232.98
Support S1 225.63 -3.16 %
S2 222.55 -4.48 %
S3 217.58 -6.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 283.23 21.57 %
R2 270.37 16.05 %
R1 265.68 14.04 %
Current price 232.98
Support S1 216.33 -7.15%
S2 201.44 -13.54%
S3 188.54 -19.07%

FAQ

What is the symbol for Madrigal Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Madrigal Pharmaceuticals, Inc. is MDGL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Madrigal Pharmaceuticals, Inc. Stock?
The Madrigal Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Madrigal Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Madrigal Pharmaceuticals, Inc. Stock?
Madrigal Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Madrigal Pharmaceuticals, Inc. Stock.

What's the current price of Madrigal Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-04-16, the price of an Madrigal Pharmaceuticals, Inc. (MDGL) share was $232.98.

What is the 52-week high and low for Madrigal Pharmaceuticals, Inc. Stock?
The 52-week high for Madrigal Pharmaceuticals, Inc. Stock is $322.67 and the 52-week low is $119.76.

What is the market capitalization of Madrigal Pharmaceuticals, Inc. Stock?
As of the 2024-04-16, the market capitalization of Madrigal Pharmaceuticals, Inc. is 4.857B.

When is the next earnings date for Madrigal Pharmaceuticals, Inc.?
The upcoming earnings date for Madrigal Pharmaceuticals, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals. Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745,... MDGL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT